PT-141 Bremelanotide 10mg

PT-141 10mg – Ultra-Pure Melanocortin Peptide for Advanced Research

PT-141, also known as Bremelanotide, is a synthetic cyclic peptide derived from α-melanocyte-stimulating hormone (α-MSH). It is widely utilised in preclinical research for its interaction with central melanocortin receptors (notably MC3R and MC4R) involved in neurochemical signalling pathways.

Originally developed through melanocortin pathway investigation, PT-141 has been featured in multiple experimental studies examining central receptor activation, neuroendocrine communication and behaviour-related signalling mechanisms in controlled research models.

⚙️

Peptide Specifications

• Synonyms: PT-141, Bremelanotide, Melanocortin Peptide, MC4R Agonist
• Sequence: Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys-NH₂
• Molecular Formula: C₅₀H₆₈N₁₄O₁₀
• Molecular Weight: ~1025.2 g/mol
• Appearance: White lyophilised powder
• Purity: ≥99%+ (HPLC verified)
• Solubility: Sterile water or dilute acetic acid (lab use only)
• Storage: 2–8 °C (short term) / –20 °C (long term)
• Packaging: 10mg glass research vial, free from additives

🧪

Scientific Insight & Research Context

• Melanocortin Pathway Studies: Used in experimental models investigating central MC3R and MC4R receptor activation and downstream signalling
• Neurochemical Signalling: Employed in research exploring hypothalamic pathways and central neurochemical modulation
• Comparative Research: Sometimes evaluated alongside other melanocortin-related analogues (e.g. α-MSH derivatives) in studies of receptor selectivity and central pathway mapping

Published literature continues to position PT-141 (Bremelanotide) as a relevant compound for ongoing investigation within research settings focused on melanocortin receptor biology and central signalling networks.

🧪 For Laboratory Research Use Only

Not intended for human consumption or therapeutic application.